- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- February 2025
- 207 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- November 2024
- 174 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- August 2024
- 200 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- December 2024
- 204 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2025
- 219 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- January 2025
- 194 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- December 2024
- 196 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2024
- 157 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2024
- 159 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- September 2024
- 158 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- September 2024
- 173 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 170 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 168 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 131 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 184 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 139 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 182 Pages
Global
From €2275EUR$2,500USD£1,951GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more